» Articles » PMID: 7509825

CD40 Preferentially Costimulates Activation of CD4+ T Lymphocytes

Overview
Journal J Immunol
Date 1994 Feb 15
PMID 7509825
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

CD40 is a membrane differentiation antigen constitutively expressed on B cells that induces B cell growth and Ig synthesis after ligation with anti-CD40 mAb or with the recently identified CD40 ligand (CD40L). CD40L is rapidly induced on T cells after activation with anti-CD3 mAb or mitogens. While CD40-CD40L interactions are clearly beneficial to B cells, we speculated that a reciprocal costimulation of T cells might also occur. We have used genetic transfection to demonstrate that interactions between human small, resting T cells and CD40+ murine transfectants substantially augmented anti-CD3 induced T cell proliferation and resulted in the generation of CTL. T cell proliferation costimulated by CD40 was IL-2 dependent. The ability of CD40+ transfectants to costimulate T cell proliferation was specific in that VCAM-1+, CD54+, CD72+, CD56+, CD31+, and fas+ transfectants in the same host cells were inactive. CD4+ T cells preferentially responded to CD40 costimulation, whereas CD8+ T cells were substantially less reactive. By contrast, costimulation with B7 transfectants induced equivalent proliferation in the CD4+ and CD8+ T cell subsets. In addition, adult naive and memory T cells, as well as cord blood T cells, were responsive to CD40. These findings suggest that the CD40-CD40L costimulation pathway may allow for selective expansion of CD4+ T cells after interaction with CD40-bearing APC. The relatively restricted expression of CD40 on APC, as well as on medullary and cortical thymic epithelium, indicates a possible role for this interaction in T cell differentiation and activation.

Citing Articles

IL-21 conditions antigen-presenting human γδ T-cells to promote IL-10 expression in naïve and memory CD4 T-cells.

Tyler C, Hoti I, Griffiths D, Cuff S, Andrews R, Keisker M Discov Immunol. 2024; 3(1):kyae008.

PMID: 38903247 PMC: 11187773. DOI: 10.1093/discim/kyae008.


Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts.

Wosen J, Mukhopadhyay D, Macaubas C, Mellins E Front Immunol. 2018; 9:2144.

PMID: 30319613 PMC: 6167424. DOI: 10.3389/fimmu.2018.02144.


Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumors.

Jindal V, Arora E, Gupta S Med Oncol. 2018; 35(6):87.

PMID: 29730801 DOI: 10.1007/s12032-018-1149-9.


Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets.

Ma C, Wong N, Rao G, Nguyen A, Avery D, Payne K J Exp Med. 2016; 213(8):1589-608.

PMID: 27401342 PMC: 4986526. DOI: 10.1084/jem.20151467.


Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression.

Curran K, Seinstra B, Nikhamin Y, Yeh R, Usachenko Y, van Leeuwen D Mol Ther. 2015; 23(4):769-78.

PMID: 25582824 PMC: 4395796. DOI: 10.1038/mt.2015.4.